{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:37:30Z","timestamp":1707525450964},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,16]]},"DOI":"10.7759\/cureus.48897","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:08:19Z","timestamp":1700150899000},"source":"Crossref","is-referenced-by-count":0,"title":["The Resolution of a Cerebrovascular Accident With Phlebotomy in a Hemodialysis Patient With Sickle Cell Disease"],"prefix":"10.7759","author":[{"given":"Azeberoje","family":"Osueni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfi","family":"Alasadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farla","family":"Jean-Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurin","family":"Sergiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Spitalewitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09960911","article-title":"The new FDA labeling for ESA--implications for patients and providers","volume":"7","author":"Manns BJ","year":"2012","unstructured":"Manns BJ, Tonelli M. The new FDA labeling for ESA--implications for patients and providers. Clin J Am Soc Nephrol. 2012, 7:348-53. 10.2215\/CJN.09960911","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12403","article-title":"Management of the dialysis patient with sickle cell disease","volume":"29","author":"Boyle SM","year":"2016","unstructured":"Boyle SM, Jacobs B, Sayani FA, Hoffman B. Management of the dialysis patient with sickle cell disease. Semin Dial. 2016, 29:62-70. 10.1111\/sdi.12403","journal-title":"Semin Dial"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00540-9","article-title":"The nephropathy of sickle cell trait and sickle cell disease","volume":"18","author":"Ataga KI","year":"2022","unstructured":"Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol. 2022, 18:361-77. 10.1038\/s41581-022-00540-9","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.435","article-title":"Chronic organ failure in adult sickle cell disease","volume":"2017","author":"Vichinsky E","year":"2017","unstructured":"Vichinsky E. Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017, 2017:435-9. 10.1182\/asheducation-2017.1.435","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong K","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998, 91:288-94.","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139x.2000.00036.x","article-title":"Hematocrit level associated mortality in hemodialysis patients, by Ma JZ, Ebben J, Xia H, Collins AJ. J Am Soc Nephrol 10:610-619, 1999","volume":"13","author":"Khan S","year":"2000","unstructured":"Khan S, Pereira BJ. Hematocrit level associated mortality in hemodialysis patients, by Ma JZ, Ebben J, Xia H, Collins AJ. J Am Soc Nephrol 10:610-619, 1999. Semin Dial. 2000, 13:112-3. 10.1046\/j.1525-139x.2000.00036.x","journal-title":"Semin Dial"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.270","article-title":"Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)","volume":"82","author":"Dr\u00fceke TB","year":"2012","unstructured":"Dr\u00fceke TB, Parfrey PS. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int. 2012, 82:952-60. 10.1038\/ki.2012.270","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.09.002","article-title":"New options for the anemia of chronic kidney disease","volume":"7","author":"Coyne DW","year":"2017","unstructured":"Coyne DW, Goldsmith D, Macdougall IC. New options for the anemia of chronic kidney disease. Kidney Int Suppl (2011). 2017, 7:157-63. 10.1016\/j.kisu.2017.09.002","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.35","article-title":"Chapter 3: Use of ESAs and other agents to treat anemia in CKD","volume":"2","year":"2012","unstructured":"Chapter 3. Use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl (2011). 2012, 2:299-310. 10.1038\/kisup.2012.35","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0929-693x(00)88740-0","article-title":"[Prevention of sickle cell crises with multiple phlebotomies] (Article in French)","volume":"7","author":"Boucha\u00efr N","year":"2000","unstructured":"Boucha\u00efr N, Manigne P, Kanfer A, et al.. [Prevention of sickle cell crises with multiple phlebotomies] (Article in French). Arch Pediatr. 2000, 7:249-55. 10.1016\/s0929-693x(00)88740-0","journal-title":"Arch Pediatr"},{"key":"ref11","article-title":"End-stage renal disease in patients with sickle cell disease","volume":"28","author":"Alkhunaizi AM","year":"2017","unstructured":"Alkhunaizi AM, Al-Khatti AA, Al-Mueilo SH, Amir A, Yousif B. End-stage renal disease in patients with sickle cell disease. Saudi J Kidney Dis Transpl. 2017, 28:751-7.","journal-title":"Saudi J Kidney Dis Transpl"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114070-the-resolution-of-a-cerebrovascular-accident-with-phlebotomy-in-a-hemodialysis-patient-with-sickle-cell-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:29Z","timestamp":1707509489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114070-the-resolution-of-a-cerebrovascular-accident-with-phlebotomy-in-a-hemodialysis-patient-with-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.48897","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}